Guardant Health (GH) Change in Receivables (2017 - 2026)

Guardant Health has reported Change in Receivables for 10 years, with the latest figure at $6.9 million in Q2 2026.

• Quarterly Change in Receivables fell 51.88% year-over-year to $6.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $13.7 million (down 54.47% YoY) and the FY2025 annual result came in at $28.2 million, up 31.73% from the prior year.
• Change in Receivables improved to $6.9 million in Q2 2026 per GH's latest filing, from -$942000.0 in the prior quarter.
• Over five years, Change in Receivables peaked at $22.2 million in Q4 2025 and troughed at -$14.5 million in Q3 2025.
• A 5-year average of $2.6 million and a median of $2.0 million in 2023 frame the typical range for Change in Receivables.
• The widest YoY moves for Change in Receivables: up 120683.33% in 2024, down 616.19% in 2024.
• Over 5 years, Change in Receivables stood at $11.1 million in 2022, then plunged by 100.16% to -$18000.0 in 2023, then jumped by 120683.33% to $21.7 million in 2024, then rose by 2.3% to $22.2 million in 2025, then sank by 68.99% to $6.9 million in 2026.
• According to Business Quant data, Change in Receivables over the past three periods registered $6.9 million, -$942000.0, and $22.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.